Crossing the tipping point: Probing the significance and biological drivers of the mechanobiological shift from tendon adaptation to pathology

Mechanical loading is central to tendon homeostasis but presents a physiological paradox, in that appropriate loading promotes adaptive remodelling and structural reinforcement, whereas excessive or prolonged loading without adequate recovery can drive pathological degeneration. Although the end-points of adaptation and tendinosis are well described, the temporal boundary and the biological processes governing the transition remain incompletely defined. In a recent study published in The Journal of Physiology, Lin et al. (2025) addressed this problem by longitudinally characterizing the cellular, molecular, structural and mechanical consequences of sustained overload, providing a time-resolved view of the shift from early adaptation to later degeneration. Lin et al. (2025) investigated the temporal threshold between physiological adaptation and pathological degeneration using a longitudinal synergistic ablation (SynAb) model. Female Long–Evans rats underwent bilateral Achilles tenectomy to increase loading of the plantaris tendon and were compared with sham and intact control animals at 3 days, 8 weeks and 16 weeks postintervention. Using activity monitoring, high-field MRI, uniaxial tensile testing, histology and second harmonic generation (SHG) imaging, Ki67 immunohistochemistry and qRT-PCR, they mapped multiscale responses over time. At 3 days, SynAb elicited an acute reparative response, with increased cellularity and broad upregulation of genes related to extracellular matrix synthesis, degradation (Mmp2 and Mmp3) and inflammation (Tnfα, Il1β and Il6). At 8 weeks, tendons were hypertrophic and showed increased ultimate load with preserved material properties, alongside downregulation of multiple matrix, regulatory and inflammatory transcripts relative to intact control animals in both SynAb and sham groups. By 16 weeks, despite persistent hypertrophy, material quality declined, with reduced linear modulus and ultimate tensile stress accompanied by increased inflammatory and matrix degradation markers, including elevated Mmp2 and higher Tnfα and Il6 versus intact controls. MRI at 16 weeks showed an increased tendon–tibia angle and a trend towards greater adjacent scar volume from 8 to 16 weeks in SynAb, consistent with altered plantaris positioning and load distribution. Notably, these degenerative mechanical and molecular changes occurred without overload-associated collagen fibre disorganization by SHG at the microscale. Overall, Lin et al. (2025) conclude that a tipping point between 8 and 16 weeks marks the failure of adaptive remodelling and emergence of a tendinosis-like degenerative phenotype. These findings establish an important framework for defining mechanobiological boundaries between adaptive remodelling and pathological degeneration, motivating further interrogation of the drivers of functional decline and highlighting candidate targets for intervention. The paragraphs that follow outline several interpretive perspectives on the broader significance of this work, beginning with translational and therapeutic implications. The synergist ablation model of Lin et al. (2025) has translational value because it frames tendon pathology as a time-dependent transition rather than a binary healthy versus diseased state. Overloading initially produces enlargement and higher failure load consistent with compensation, but continued overload crosses a threshold where material quality falls (reduced modulus and ultimate stress) alongside increased inflammatory and matrix degradation signalling. This time course defines a therapeutic window between early hypertrophy and late-stage failure, when reducing cumulative load, optimizing recovery and limiting maladaptive extracellular matrix turnover might prevent entry into a self-reinforcing catabolic state. The model also highlights the peritendinous compartment as more than bystander tissue. Sheath growth and scarring can alter boundary conditions, restrict excursion and gliding, and create heterogeneous stress fields that sustain injury even if the tendon core remains relatively organized. This broadens treatment logic towards controlling peritendinous fibrosis and oedema and restoring tissue sliding interfaces, and it suggests that dampening profibrotic programmes in the sheath could reduce tethering and load vector distortion that accelerate degeneration. Finally, the data caution against treating enlargement alone as successful adaptation, because functional hypertrophy might be difficult to distinguish from oedematous or scar-associated swelling that is permissive for later failure, with implications for load prescription and titration of rehabilitation. These principles are likely to extend to other dense connective tissues with hierarchical collagen architectures and load-transfer interfaces, including ligaments, aponeuroses and deep fascia, where overload can shift in a similar manner from adaptive thickening to impaired material integrity. In deep fascia, scar-mediated restriction and loss of shear plane gliding would be expected to disrupt myofascial force transmission, providing a plausible parallel to how peritendinous scarring in tendon can drive progressive mechanical dysfunction. However, some translational inferences warrant closer scrutiny because the multiscale results suggest partial uncoupling of structure, mechanics and inflammatory signalling over time. The following paragraphs therefore offer additional plausible, mechanistically grounded interpretations of the late decline in material quality, the potential contribution of the peritendinous sheath to scar-mediated load redistribution and inflammatory persistence, and whether the mid-stage ‘adaptive’ phenotype instead reflects an earlier homeostatic disturbance that precedes overt degeneration. A key observation is that by 16 weeks, linear modulus and ultimate stress fall, despite no overload-associated collagen fibre disorganization by microscale SHG dispersion (Lin et al., 2025). One explanation is collagen molecular denaturation accumulating with loading, which can be present even when gross fibre architecture appears preserved and which can be detected using denatured collagen-targeting probes (Fang et al., 2024). A second, structurally speci­-fic explanation is selective failure of the interfascicular matrix, which enables fascicle sliding and recoil and is often the first compartment to accumulate fatigue microdamage, increasing compliance before fascicle rupture (Thorpe et al., 2015). Together, these mechanisms support a testable interpretation that late-stage weakening reflects molecular collagen damage and/or interfascicular matrix dysfunction, with possible contributions from inter-/intramolecular crosslinking, aqueous matrix remodelling or changes in non-collagenous fibrous components that degrade material quality without generating large-scale fibre disorder detectable by SHG (Fang et al., 2024; Thorpe et al., 2015). Beyond intratendinous remodelling, the data in the study by Lin et al. (2025) implicate the peritendinous sheath as a potential upstream driver of the evolving response. The early Ki67 signal is concentrated in the peritendinous compartment rather than the tendon core, suggesting that extrinsic tissues contribute substantially to the initial cellular expansion. This is consistent with Nichols et al. (2025), who used GLASTCreERT (glial high-affinity glutamate transporter (GLAST) promoter–driven tamoxifen-inducible Cre recombinase) lineage tracing to show that epitenon progenitors expand after injury and adopt divergent fates:t some contribute to organized bridging tissue with tenogenic programmes, whereas others form a peripheral, adhesion-associated capsule enriched for pro-inflammatory and profibrotic markers, including CXCL14. In this framework, the peritendinous scar burden in the model used by Lin et al. (2025) could reflect active expansion of extrinsic fibroblastic lineages arising from the adjacent Achilles injury scar/epitenon rather than a passive byproduct of tendon disruption. If such a pro-inflammatory lineage persists, it could also help to explain the re-elevation of Il6 and Tnfα gene expression at 16 weeks as a consequence of unresolved extrinsic fibrosis rather than intrinsic tenocyte degeneration, although this requires evidence that these cells remain present and transcriptionally active at chronic time points. However, Lin et al. (2025) did not profile peritendinous tissues longitudinally and did not report a discernible plantaris peritendinous sheath at 8 or 16 weeks; thus, any late extrinsic contribution is more plausibly mediated by cross-talk with the adjacent Achilles scar and associated changes in boundary conditions and load distribution than by persistent hypercellularity of a native plantaris sheath. More broadly, early sheath-centred proliferation might act as an upstream determinant of whether scar-driven load redistribution becomes a dominant modifier of tendon mechanics despite preserved intratendinous fibre alignment. We therefore frame the proposed sheath contribution at 16 weeks as hypothesis generating and best addressed with compartment-resolved analyses. A further, non-mutually exclusive explanation is that late inflammatory reactivation reflects a shift in resident cell state rather than a new cytokine surge. In tendinopathy, stromal fibroblasts might become persistently ‘primed’, amplifying catabolic remodelling under continued load, often with immune cell involvement. This supports adding cell-type-resolved readouts (immune composition and stromal activation markers) beyond bulk cytokine transcripts to separate persistent stromal activation from transient wound remodelling. The interpretation of the phenotype at 8 weeks as ‘adaptive’ merits additional nuance when considered alongside early human tendinopathy biology. Lin et al. (2025) label 8 weeks adaptive because tendon cross-sectional area is increased and material properties are preserved despite downregulation of extracellular matrix synthesis genes. However, tendon enlargement can arise from substrates not distinguished by the current readouts, including true matrix accretion versus compositional shifts, such as altered hydration. Consistent with this, early human tendinopathy studies report that within the first 3 months, tendons can be enlarged and hypervascularized, without detectable reductions in stiffness or broad increases in matrix and growth factor transcripts in biopsy tissue (Tran et al., 2020). This supports the possibility that the ‘hypertrophy’ at 8 weeks in the SynAb model might partly reflect disturbed homeostasis and increased water content rather than definitive structural reinforcement. Although the phenotype at 8 weeks could represent an early disturbance that precedes the material decline and inflammatory reactivation at 16 weeks, future studies should quantify tissue composition and molecular damage directly. Finally, although this study maps a clear temporal trajectory, key conclusions rely on bulk, largely correlative readouts (mechanics, SHG alignment and bulk transcripts) that cannot assign causality to specific tendon subcompartments or cell populations, nor fully disentangle overload effects from surgery- and scar-driven changes. Uniaxial tests in isolated tendons also capture bulk properties but under-represent the multidirectional, regionally heterogeneous strain and shear experienced in vivo, supporting the use of complementary loading or imaging approaches that better approximate these states. The present gaps could also be addressed by validating the proposed thresholds in non-invasive, graded loading protocols across both sexes and wider age ranges, coupled with compartment- and cell-type-resolved profiling and direct assays of molecular matrix damage. Technically, moving beyond bulk tissue analysis with single-cell or spatial transcriptomics could localize the late inflammatory signal and distinguish peritendinous progenitor expansion from intrinsic tenocyte priming. Ultimately, by pinpointing the precise molecular switches that govern the 8-to-16-week transition, research can pivot from treating established tendinosis to developing preventative strategies that actively sustain the adaptive remodelling phase. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. None declared. All authors have read and approved the final version of this manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed. We were supported by a research grant from the Slovenian Research and Innovation Agency (grant no. P3-0043). We are sincerely grateful to Assistant Professor Nejc Umek for his valuable insights and many stimulating discussions.